Congratulations to MassNextGen Entrepreneur Joanna Stanicka and her team at Axonis Therapeutics which announced today $115 million series A financing to support the development of novel neuromedicines targeting KCC2.
This is the largest raise in a single round for any Mass NextGen awardee. The company has also grown its team leveraging the MLSC’s internship programming.
